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Abstract Advances in genetic testing and the availability of
such testing in pregnancy allows prospective parents to test
their future child for adult-onset conditions. This ability raises
several complex ethical issues. Prospective parents have re-
productive rights to obtain information about their fetus. This
information may or may not alter pregnancy management.
These rights can be in conflict with the rights of the future
individual, who will be denied the right to elect or decline
testing. This paper highlights the complexity of these issues,
details discussions that went into the National Society of
Genetic Counselors (NSGC) Public Policy Task Force’s de-
velopment of the Prenatal testing for Adult-Onset Conditions
position statement adopted in November 2014, and cites rele-
vant literature on this topic through December 2015. Issues
addressed include parental rights and autonomy, rights of the
future child, the right not to know, possible adverse effects on
childhood and the need for genetic counseling. This paper will
serve as a reference to genetic counselors and healthcare pro-
fessionals when faced with this situation in clinical practice.
Keywords Prenatal testing . Adult-onset conditions . Genetic
counseling . Reproductive rights . Ethical issues . The
National Society of genetic counselors . Position statement
Introduction
The National Society of Genetic Counselors (NSGC) releases
position statements that are intended to convey to the public
the Society’s specific views and opinions on issues of rele-
vance to the practice of genetic counseling. The NSGC Public
Policy Committee (PPC) leads the creation of new state-
ments, or revision of existing statements, based on emerging
data or issues. This paper highlights the background informa-
tion that informed the Task Force members’ discussions and
shaped the statement on prenatal testing for adult-onset con-
ditions put forward to the NSGC membership and Board of
Directors for comments and approval, and adopted on
November 3, 2014.
NSGC’s position statement on prenatal testing for adult-onset
conditions is as follows: BThe National Society of Genetic
Counselors (NSGC) encourages deferring prenatal genetic test-
ing for adult-onset conditions if pregnancymanagement will not
be affected. Prospective parents have the right to make fully
informed and autonomous decisions about reproductive options
and pregnancy management. However, prenatal testing for
adult-onset conditions denies the future child the opportunity
tomake this decision for him/herself as an adult. NSGC strongly
recommends that prospective parents meet with a certified ge-
netic counselor or other healthcare specialist with genetic
counseling expertise for decision-making about prenatal testing.
Adopted by NSGC on 11/3/14^ (NSGC Position Statement
Prenatal Testing for Adult-Onset Conditions 2014).
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Background
As a result of advances in genetics, more genes are being iden-
tified for adult-onset conditions and there is increased availabil-
ity of genetic testing. For some adult-onset genetic conditions
(e.g. hereditary breast cancer, hereditary non-polyposis colon
cancer), genetic testing is offered so that disease surveillance
and, in some cases, prevention, can be initiated in adulthood
prior to the onset of symptoms. For other conditions (e.g.
Huntington disease, early-onset Alzheimer’s disease), pre-
symptomatic interventions are not available and testing may
be done to learn genetic status and inform life decisions.
Prenatal use of genetic testing raises its own set of issues.
The variety of genetic tests, both screening and diagnostic,
available to the prospective parent continues to expand and
can provide results as early as 9 weeks gestation (ACOG
2015). Prenatal genetic testing, in general, is now less expen-
sive, quicker and safer than in the past. Results can take days
rather than weeks, allowing for timely reproductive decision-
making. The increased availability of prenatal testing options
has raised both awareness among patients and ethical con-
cerns that challenge healthcare professionals. (Van Lith et al.
2015; Wilson et al. 2015).
The National Society of Genetic Counselors (NSGC) and
other professional organizations have discouraged testingminors
for adult-onset conditions, and they recommend deferring testing
until the individual reaches the age of majority unless there is a
compelling reason to do otherwise (ASHG/ACMG 1995;
Botkin et al. 2015; NSGC Position Statement Genetic Testing
of Minors for Adult-Onset Conditions 2012; Ross et al. 2013).
Prenatal testing for adult-onset conditions may allow tests con-
sidered inappropriate for minors to be performed in utero. If the
pregnancy continues, this means that a minor will have been
tested. However, denying the prospective parent the option of
prenatal testing would create limitations in contradiction to the
NSGC’s position on reproductive freedom, which supports the
rights of individuals and couples to make reproductive choices.
Negotiating this conflict between two principles with
strong support in the genetic counseling community was the
main concern of the Task Force as we prepared the NSGC
position statement on prenatal testing for adult-onset condi-
tions. As a Task Force, we felt strongly that a paper detailing
the deliberations and research that informed our brief state-
ment would be valuable, and serve to highlight the complicat-
ed ethical and practical issues that confront genetic counselors
and other healthcare providers working in prenatal settings
and other settings where patients are considering prenatal test-
ing for adult-onset conditions.
TheNSGCPublic PolicyCommittee identified genetic coun-
selors with experience and expertise in prenatal genetics, adult
genetics/predictive testing, and ethics. The appointed Task
Force researched other professional organizations’ statements
and conducted a literature review. Topics researched included
prenatal, presymptomatic and childhood testing for adult-onset
genetic conditions and pre-implantation genetic testing. Early in
the discussions, the Task Force decided that the scope of the
statement would focus on testing of an established pregnancy
and not pre-implantation genetic diagnosis (PGD). The Task
Force felt that the area of PGD involves a very different set of
factors, players, and policies than prenatal testing.
From the literature search and conference call discussions,
the Task Force delineated points to include in a position state-
ment, which are discussed below. The Task Force developed
the statement, submitted for a 2- week open member review,
and collected and considered comments. The revised state-
ment was sent to the NSGC Board of Directors for review
and was adopted in November 2014.
In developing the position statement on prenatal testing for
adult-onset conditions, the Task Force aimed to be consistent
with other NSGC position statements especially the statements
on Reproductive Freedom and genetic testing of Minors for
Adult-Onset Conditions. NSGC’s position statement on
Reproductive Freedom supports the right of all individuals
and couples to make reproductive choices, including the use
of Binformation from genetic counseling and/or testing to de-
cide whether to pursue a pregnancy,…. to prepare for the birth
and future needs of their offspring, to make an adoption plan, or
to end a pregnancy^ (NSGC Position Statement: Reproductive
Freedom 2010). The emphasis on patient autonomy and in-
formed decisions is further supported by the NSGC Code of
Ethics (NSGC Code of Ethics 1992). The NSGC Code of
Ethics states that BThe counselor-client relationship is based
on values of care and respect for the client’s autonomy, individ-
uality, welfare and freedom^ and that genetic counselors strive
to Benable their clients to make informed decisions, free of
coercion, by providing or illuminating the necessary facts,
and clarifying the alternatives and anticipated consequences.^
NSGC’s position statement on Genetic Testing of Minors for
Adult-Onset Conditions, adopted in 2012, Bencourages defer-
ring predictive genetic testing of minors for adult-onset condi-
tions whenever possible^ to Ballow individuals to choose for
themselves as adults, taking into account their own circum-
stances, preferences and beliefs.^ Guidelines from professional
organizations, including the American College of Medical
Genetics and Genomics, the American College of Pediatrics
and the American Society of Human Genetics, (ASHG/
ACMG 1995; Botkin et al. 2015; Ross et al. 2013) all support
deferring genetic testing of minors except in those circum-
stances when the genotypic information has some immediate
benefit such as treatment or intervention in childhood or where
testing would Balleviate substantial psychosocial distress^
(Botkin et al. 2015).
While we found position statements on the topic of testing
of minors, there was little that specifically addressed testing of
a fetus in pregnancy for adult-onset conditions. A 2008 state-
ment from the American College of Obstetricians and
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Gynecologists on BEthical Issues in Genetic Testing,^ (ACOG
2008) reaffirmed in 2014, served mainly to frame the issue: BIn
pregnancies likely to be carried to term, consideration should
be given to whether, as in the case of testing children, the
decision to test should be reserved for the child to make upon
reaching adulthood. However, consideration also should be
given to personal preference, that is, the interests individuals
may have in terminating a pregnancy that may result in a life
(such as life that will be affected by Huntington chorea) that
they feel morally obliged or prefer not to bring into the world.^
The predictive genetic testing guidelines for Huntington
disease (HD), which have been adapted for testing for other
autosomal dominant neurogenetic conditions (e.g. early-onset
Alzheimer’s disease, frontotemporal dementias), clearly state
that prenatal genetic testing should not be done if the pregnan-
cy will be continued regardless of the HD results on the
grounds that continuing a pregnancy after obtaining a positive
result for HD would be akin to testing a minor and would
deprive the future child their autonomy in deciding whether
or not to learn this information (MacLeod et al. 2013).
Ethical Considerations
Prenatal and childhood testing for adult-onset conditions
raises several ethical considerations. There are issues around
autonomy including whose autonomy takes precedence – the
parent(s) or the future child. The parent has the right to test the
pregnancy and to decide whether or not to continue the preg-
nancy based on this information. However, if the parent is
going to continue the pregnancy regardless of the results, then
there is the issue that the genetic status of a minor will be
known. Testing is offered to give prospective parents the abil-
ity to obtain information about the genetic status of their fetus
and provide the option of termination, but cannot be done with
the expectation of termination.
Reproductive Rights
The Task Force’s statement on prenatal testing for adult-onset
conditions clearly supports the prospective parents’ right to
know about the genetic status of a fetus, which is consistent
with NSGC’s position statement on reproductive freedom, but
specifically encourages deferral if pregnancy management
will not be affected.
The Task Force had lengthy discussions on whether or not
to consider the prospective parents’motivation and intentions
as a part of the decision regarding when to offer or decline
testing. Should parents have the right to test regardless of their
intended use of the information? Is it ethical for a healthcare
provider or laboratory to determine whether prospective par-
ents’ reason for prenatal testing is sufficient or acceptable to
proceed with testing? While prospective parents’ inclinations
are obviously an appropriate and important subject to address
in counseling, in the opinion of the Task Force, parents could
not be offered or denied testing based on a hypothetical dis-
cussion of their intentions. Answering hypothetical questions
is not a genuine proxy for being confronted with real results.
Prospective parents cannot be expected to focus the same way
on the decision when they are asked about a risk and not a
definite reality. Additionally, parents who say they either will
or will not terminate a pregnancy can change their minds.
Genuine reproductive choice is contingent on the access to
information. Although prospective parents are encouraged to
carefully consider their intentions in proceeding with prenatal
genetic testing, in the end, they should be provided with all the
information they need, including test results if that is their
choice, before making a decision about whether or not to con-
tinue or terminate a pregnancy. Expecting fully informed deci-
sions will be made in advance is not a reasonable expectation.
Rights of The Future Child
Controversy exists with prenatal testing for an adult-onset con-
dition because the results generally will not be used to affect the
child’s medical care in childhood. Therefore, it seems likely that
the parent is making the decision to test a pregnancy out of a
desire to know and not to benefit the child’s care. The child’s
ability to exercise his/her future autonomy to decide whether to
learn his/her genetic status and right to an open future is taken
away if the parent determines the status prenatally.
Considering beneficence/non-maleficence, there are poten-
tial harms that could result from the child having his/her ge-
netic status known including having this knowledge forced
upon him/her, being raised as a Bvulnerable child^ and poten-
tial for stigmatization and insurance discrimination (ASHG/
ACMG 1995; Green and Solnit 1964). In the absence of using
test results to affect pregnancy management or care during
childhood, the future child’s best interest needs to be a signif-
icant consideration in testing decisions.
The Right not to Know
The idea that we should decline to test minors based on the
need to preserve their autonomy is closely tied to broader argu-
ments in support of ‘the right not to know.’ The Bright not to
know^ is frequently discussed with regard to genetic testing,
and reflects a belief that rational individuals might decline to
receive the type of predictive information that can be obtained
from genetic testing, either because they would prefer not to
know, the results may not impact their medical or life decisions,
or because they are concerned about discrimination or stigma
(Borry et al. 2014; Knoppers 2014; Takala 1999). Patients can
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decline medical care or diagnostic testing that could directly
impact their physical health. Similarly, patients can decline pre-
dictive genetic testing even though there is a clear genetic risk
and established screening. For example, patients at 50 % risk to
inherit an autosomal dominant gene for breast or colon cancer
do decline genetic testing and the opportunity to perform pre-
ventativemammograms and colonoscopy (Leennen et al. 2016;
National Comprehensive Cancer Network et al. 2015). In sum-
mary, patients often make testing and management decisions
and as a consequence decline screening or treatment options,
but ultimately this is their decision to make.
Arguments surrounding the Bright not to know^ stem from
early discussions focused largely on highly penetrant and dev-
astating neurological conditions such as Huntington disease
(HD) and early-onset Alzheimer disease (AD). Uptake of the
test for HD when it became available did not match the hypo-
thetical demand, suggesting that many at-risk individuals who
had expressed an interest in testing decided against it when
presented with the actual option. (Bernhardt et al. 2009;
Creighton et al. 2003; Tassicker et al. 2009).
The Bright not to know^ is considered grounds on which an
individual can decline predictive genetic testing for him/herself
and can be applied to the recommendation to refuse parental
requests for genetic testing of their minor children for adult-
onset conditions. Our reluctance to permit parental consent in
these cases suggests a strong proclivity to defer testing, and a
high bar for what constitutes a necessary test. This approach
similarly extends to prenatal testing for adult-onset conditions
when pregnancy management will not change with the results.
Adverse Effects on Childhood
The Task Force found evidence in the literature of concern
about the possible negative consequences of early access to
genetic information on later onset conditions. These potential
ill effects – on self-esteem, on relationships between parent and
child, in terms of stigma or discrimination – are the subject of
much discussion, but few studies exist (Michie et al. 2001;
Pelias 2006). The idea of a Bvulnerable child syndrome^ was
first introduced by Green and Solnit in 1965, who suggested
that parents may become unduly overprotective or restrictive of
a child deemed Bat-risk.^A 1995 paper published jointly by the
American Society for Human Genetics (ASHG) and the
American College of Medical Genetics has a detailed list of
potential harms: a child may be over-indulged or treated as a
scapegoat, results may alter their self-image, they may have
survivor guilt or over-identify with affected family members,
their privacy may be compromised. In 2015, ASHG published
a Points to Consider document (Botkin et al. 2015) which fo-
cused on ethical, social and legal issues in the genetic testing of
children associated with specific technology utilized, such as
genome-scale sequencing, chromosome microarray, direct-to-
consumer testing, pharmacogenomic testing, and newborn
screening. The paper acknowledged that only a modest volume
of clinical research has been conducted regarding the impact of
predictive testing in high-risk families, but that this limited re-
search has not found evidence of significant psychosocial
harms in children.
Well-structured, systematic studies have yet to be performed
to examine the psychosocial outcomes for children who under-
go genetic testing. Wade et al. (2010) performed a review of
literature spanning 30 years to identify studies that assessed the
impact of communicating carrier (e.g. cystic fibrosis, Tay-
Sachs disease) or presymptomatic (e.g. familial adenomatous
polyposis, hypertrophic cardiomyopathy) genetic test results to
children. Although there was little quantitative evidence of neg-
ative impact of genetic test results on a child’s psychosocial
wellbeing, it was recognized that inconsistencies with method-
ology and psychopathology measures and small samples made
it difficult for the authors to make any firm conclusions.
In the absence of outcomes data, the theoretical concerns
regarding the impact of genetic testing of minors for adult onset
conditions can be applied to prenatal disclosure of gene status,
and ethical issues such as the right not to know or the right of a
child to an open future must be seriously considered. In en-
couraging deferral of testing in situations where it will not alter
pregnancy management, we emphasize the importance of
protecting the best interests of the future child. However, we
recognize the reproductive rights of prospective parents as par-
amount when conflicts cannot be resolved. As a consequence
of protecting the parents’ reproductive rights, we accept that at
times children will be born having already had genetic tests
which are widely considered inappropriate for minors. To keep
those circumstances to a minimum, we recommend that pro-
spective parents are counseled by genetics professionals and
consider the use of other consultations as necessary, including a
hospital ethics board and the NSGC Ethics Advisory Group.
Other Considerations
Potential insurance ramifications are a concern when testing
for adult-onset conditions prenatally. Although health insur-
ance is currently a protected entity under federal law (The
Genetic Information Nondiscrimination Act of 2008), long-
term care insurance, long-term disability and life insurance
are not covered in this legislation. There is great variation in
state law (National Human Genome Research Institute
Genome Statute and Legislation Database n.d.), and not all
of these laws would prevent insurers from denying a policy
based on a pre-existing genetic test result. For individuals
facing the possibility of a neurodegenerative or other severe
disease, maintaining access to long-term care and long-term
disability insurance is a significant consideration.
Theoretically, individuals may be denied long-term care or life
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insurance based on family history. However, a positive genetic
test may increase that likelihood, and the individual may be
seen as pre-symptomatic, rather than at-risk. If genetic testing
occurs prenatally, it removes the option for the future individ-
ual to procure appropriate insurance protection before seeking
a risk assessment or genetic diagnosis. This risk of insurance
discrimination is further complicated by the parental decision
to disclose or not disclose this information to the future indi-
vidual, who will be unaware of his/her genetic testing status.
Another issue raised in our deliberations, and in the re-
sponse from the NSGC membership, was whether or not to
consider characteristics of the condition as a part of the deci-
sion about whether or not to proceed with prenatal testing. The
Task Force also discussed the ever-growing menu of genetic
testing both in technique and scope of conditions offered.
Testing falls into two main categories: targeted and non-
targeted. For the purposes of our discussion we defined
targeted as a test for a single gene associated with a known
disorder suspected in the patient, and non-targeted as any
multi-gene test including panels (including targeted panels),
array genomic hybridization, or whole exome sequencing.
During pregnancy, targeted testing for a given gene or condi-
tion can be performed if there is a positive family history,
abnormal ultrasound and/or other prenatal findings suggestive
of a specific condition. For targeted testing, pretest counseling
can reasonably include specific considerations including se-
verity, age of onset, degree of penetrance and the availability
of treatment. Prospective parents may have personal or famil-
ial experience with the condition under consideration, which
may influence their perception of risk and drive their testing
decisions. Recommendations for pretest counseling often pre-
sume that these aspects of the disease can and should be
discussed with prospective parents before testing.
Non-targeted testing may be performed when a genetic con-
dition is suspected but has not been identified, when a diagnosis
has been made but the genetic etiology is unknown, or as a
screen in the absence of any family history or medical finding.
In this sense non-targeted testing changes the nature of pre-test
counseling and may challenge current standards. In consider-
ation of this issue we did not think it was wise or practical to
tether the position statement on prenatal testing for adult-onset
conditions to any specific set of circumstances or conditions.
We acknowledge that as the use of prenatal testing changes, it
may be necessary to re-visit this issue and provide revised
guidelines regarding appropriate use of testing.
Need for Pre-Test Genetic Counseling
Given the complex issues raised by prenatal genetic testing for
adult-onset conditions, we thought it was important to strong-
ly recommend that prospective parents receive pre-and post-
test genetic counseling. In addition, feedback from the NSGC
membership stressed the need for counseling with a clinician
with genetics expertise in order to help prospective parents
understand these complex testing issues and the responsibili-
ties associated with becoming custodians of their future
child’s genetic information. Genetic counseling should occur
before testing is performed to ensure parents understand the
practical and ethical considerations and provide informed con-
sent for testing. It is equally important for parents to receive
post-test counseling once results are available to ensure that
they understand the implications and to explore pregnancy
management options. As discussed above, parents may intend
to terminate a pregnancy for a positive result, but could
change their minds once results are tangible.
The Task Force carefully worded this recommendation for
genetic counseling to emphasize the expertise needed. We did
not want to suggest that the interest in counseling was tied
only to genetic counselors and wanted to be inclusive in rec-
ognizing providers who have this expertise. Other NSGC po-
sition statements have similarly included the need for genetic
counseling. Consistent with this recommendation, the HD
predictive testing guidelines regarding prenatal testing specif-
ically note the need for Bcareful pre-test counselling by an
informed professional^ and having this occur in a Bspecialized
(prenatal or genetics) centre.^ (MacLeod et al. 2013).
While the position statement uses the wording Bmeet with^
we recognize that genetic counseling services may not be
locally available and such discussions may take place through
genetic counseling services offered by teleconferencing,
phone or other modalities.
Future Directions
Rapidly changing genetic technology will continue to influ-
ence the scope of prenatal genetic testing. The Task Force
recognized these likely changes and discussed how to best
address them in the guidelines for prenatal testing for adult-
onset conditions. Genetic testing will likely move away from
targeted, single gene testing for a specific indication and to-
wards non-targeted genomic testing for the general pregnant
population and have the capability of identifying gene variants
for adult-onset conditions. Whole exome sequencing (WES),
commonly performed post-birth, is now being offered prena-
tally in specific cases (Carss et al. 2014, Hillman et al. 2015).
Eventually, WES may shift to the general low-risk pregnant
population if studies support the validity and accuracy of test-
ing and costs decrease (Gregg et al. 2013). Non-invasive pre-
natal tests are rapidly increasing in popularity and have been
shown in principle to be capable of providing a full fetal ge-
notype in the first trimester (Kitzman et al. 2012). Given the
real possibility of continued advances, we decided not to focus
on a specific testing methodology but rather write guidelines
that could be applied to a broad range of testing.
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The increasing availability and marketing of genetic tests
will likely increase both the healthcare providers’ and the pub-
lic’s familiarity with genetics and the inherent uncertainty of
predictive genetic information. Concerns such as stigma, genet-
ic discrimination, vulnerable child syndrome and difficulties in
obtaining insurance may or may not wane over time. Studies to
examine patient outcomes of prenatal genetic testing for adult-
onset conditions will be helpful to assess the true uptake of
testing and implications. The Task Force supports continued
research to investigate patient outcomes of prenatal testing for
adult-onset conditions and the ethical, legal and social impact.
Conclusion
We acknowledge the primacy to the prospective parents’ right
to make autonomous reproductive decisions, and the impossi-
bility of requiring individuals to predict their own course of
action in advance of being fully informed, which may, in some
instances, include seeking and obtaining results of genetic tests.
Genetic counseling is important to advise prospective parents
of the possible consequences of prenatal genetic testing and
why testing may not be in the best interests of their future child.
However, any conflict between the right of prospective parents
to obtain information and the right of the future child should
generally be resolved in favor of the parents.
Acknowledgments We thank the NSGC Membership and Board of
Directors for the valuable comments and feedback they provided in the
formation and revisions of this position statement.
Compliance with Ethical Standards
Conflict of Interest Authors Laura Hercher, Wendy Uhlmann, Erin
Hoffman, Shanna Gustafson, and Kelly Chen declare that they have no
conflict of interest.
Animal Studies No animal studies were carried out by the authors for
this article.
References
American College of Obstetricians and Gynecologists (2008). Ethical
issues in genetic testing. ACOG Committee opinion no. 410.
Obstetrics and Gynecology, 111, 1495–1502.
American College of Obstetricians and Gynecologists (2015). Cell-free
DNA screening for fetal aneuploidy. ACOG Committee opinion no.
640. Obstetrics and Gynecology, 126, e31–e37.
American Society of Human Genetics Board of Directors; American
College of Medical Genetics; Board of Directors (1995). Points to
consider: ethical, legal, and psychosocial implications of genetic
testing in children and adolescents. American Journal of Human
Genetics, 57, 1233–1241.
Bernhardt, C., Schwan, A., Kraus, P., Epplen, J., & Kuntsmann, E. (2009).
Decreasing uptake of predictive testing for Huntington’s disease in a
GermanCentre: 12 years’ experience (1993-2004).European Journal
of Human Genetics, 17, 295–300. doi:10.1038/ejhg.2008.164.
Borry, P., Shabani, M., &Howard, H. (2014). Is there a right time to know?
The right not to know and genetic testing in children. Journal of Law,
Medicine and Ethics, 42, w19–w27. doi:10.1111/jlme.12115.
Botkin, J., Belmont, J., Berg, J., Berkman, B., Bombard, Y., Holm, I.,
Levy, H., et al. (2015). Points to consider: ethical, legal, and psy-
chosocial implications of genetic testing in children and adolescents.
American Journal of Human Genetics, 97, 6–21. doi:10.1016/j.
ajhg.2015.07.013.
Carss, K., Hillman, S., Parthiban, V., McMullan, D., Mahrer, E., Kilby, M.,
& Hurles, M. (2014). Exome sequencing improves genetic diagnosis
of structural fetal abnormalities revealed by ultrasound Human
Molecular Genetics, 23, 3269–3277. doi:10.1093/hmg/ddu038.
Creighton, S., Almqvist, E., MacGregor, D., Fernandez, B., Hogg, H.,
Beis, J., Welch, J., et al. (2003). Predictive, pre-natal and diagnostic
genetic testing for Huntington’s disease: the experience in Canada
from 1987 to 2000. Clinical Genetics, 63, 462–475.
Green M, Solnit AJ (1964). Reaction to the threatened loss of a child: a
vulnerable child syndrome. Pediatrics, 34, 53–66.
Gregg, A., Gross, S., Best, R., Monaghan, K., Bajaj, K., Skotko, B.,
Thompson, B., et al. (2013). ACMG statement on noninvasive pre-
natal screening for fetal aneuploidy Genetics in Medicine, 15, 395–
388. doi:10.1038/gim.2013.29.
Hillman, S., Williams, D., Carss, K., McMullan, D., Hurles, M., & Kilby,
M. D. (2015). Prenatal exome sequencing for fetuses with structural
abnormalities: the next step. Ultrasound in Obstetrics &
Gynecology, 45, 4–9. doi:10.1002/uog.14653.
Kitzman, J., Snyder, M., Ventura, M., Lewis, A., Qiu, R., Simmons, L.,
Gammill, H., et al. (2012). Noninvasive whole-genome sequencing
of a human fetus. Science Translational Medicine, 4, 137ra76. doi:
10.1126/scitranslmed.3004323.
Knoppers, B. M. (2014). From the right to know to the right not to know.
Journal of Law, Medicine and Ethics, 42, 6–10. doi:10.1111
/jlme.12113.
Leennen, C. H., Heijer, M. D., van der Meer, C., Kuipers, E. J., van
Leerdam, M. E., & Wagner, A. (2016). Genetic testing for lynch
syndrome: family communication and motivation. Familial
Cancer, 15(1), 63–73. doi:10.1007/s10689-015-9842-8.
MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Jones, A.,
Martinz-Descales, A., & Editorial Committee and Working Group
BGenetic testing Counselling^ of the European Huntington Disease
Network. (2013). Recommendations for the predictive genetic test
in Huntington's disease. Clinical Genetics, 83, 221–231.
doi:10.1111/j.1399-0004.2012.01900.
Michie, S., Bobrow, M., Marteau, T., & on behalf of the FAP
Collaborative Research Group. (2001). Predictive genetic testing
in children and adults: a study of emotional impact. Journal of
Medical Genetics, 38, 519–526. doi:10.1136/jmg.38.8.519.
National Comprehensive Cancer Network, NCCN Guidelines, Genetic/
Familial High Risk Assessment: Breast and Ovarian, 2.(2015).
Retrieved November 1, 2015 from http://www.nccn.org/.
National Human Genome Research Institute Genome Statute and
Legislation Database (n.d.). Retrieved from http://www.genome.
gov/PolicyEthics/LegDatabase/pubsearch.cfm.
National Society of Genetic Counselors (1992). NSGC Code of Ethics.
Retrieved November 1, 2015 from http://nsgc.org/p/cm/ld/fid=12.
National Society of Genetic Counselors (2010). NSGC Position
Statement: Reproductive Freedom. Retrieved November 1, 2015
from http://nsgc.org/p/bl/et/blogaid=35.
National Society of Genetic Counselors (2012) NSGC Position Statement:
Genetic Testing of Minors for Adult-Onset Conditions. Retrieved
November 1, 2015 from http://nsgc.org/p/bl/et/blogaid=28.
1144 Hercher et al.
National Society of Genetic Counselors (2014). NSGC Position
Statement: Prenatal Testing for Adult-Onset Conditions. Retrieved
November 1, 2015 http://nsgc.org/p/bl/et/blogaid=259.
Pelias, M. (2006). Genetic testing of children for adult-onset diseases: is
testing in the child's best interests? Mt. Sinai Journal of Medicine,
73, 605–608.
Ross, L., Saal, H., David, K., Anderson, R., & the American Academy of
Pediatrics; American College of Medical Genetics and Genomics
(2013). Technical report: ethical and policy issues in genetic testing
and screening of children. Genetics in Medicine, 15, 234–245.
doi:10.1038/gim.2012.176.
Takala, T. (1999). The right to genetic ignorance confirmed. Bioethics,
13, 288–293. doi:10.1111/1467-8519.00157.
Tassicker, R., Teltscher, B., Trembath, M., Collins, V., Sheffield, L., Chiu,
E., Gurrin, L., & Delatycki, M. (2009). Problems assessing uptake of
Huntington disease predictive testing and a proposed solution.
European Journal of Human Genetics, 17, 66–70. doi:10.1038
/ejhg.2008.
Van Lith, J., Faas, B., & Bianchi, D. (2015). Current controversies in
prenatal diagnosis 1: NIPT for chromosome abnormalities should
be offered to women with low a priori risk. Prenatal Diagnosis, 35,
8–14. doi:10.1002/pd.4530.
Wade, C., Wilfond, B., & McBride, C. (2010). Effects of genetic risk
information on children’s psychosocial wellbeing. Genetics in
Medicine, 12, 317. doi:10.1097/GIM.0b013e3181de695c.
Wilson, R., Ledbetter, D., & Pergament, E. (2015). Current controversies
in prenatal diagnosis 3: the ethical and counseling implications of
new genomic technologies: all pregnant women should be offered
prenatal diagnostic genome-wide testing for prenatally identified
fetal congenital anomalies. Prenatal Diagnosis, 35, 19–22.
doi:10.1002/pd.4531.
Prenatal Testing for Adult-Onset Conditions 1145
